薬剤耐性（AMR）の現状及び - mhlw.go.jp

1 AMR (AMR) 28 6 10 1 17 (AMR antimicrobial resistance ) AMR AMR WHO AMR 2 G7 AMR G7 G7 AMR WHO AMR G7 AMR Sch berle TF , Hack IM,Trends Microbiol. 2014; 22: 165-7. ICU 2 ( ) 3 4 52000 10 Van Boeckel TP et al.

2 , Lancet Infect Dis 2014; 14: 742-50. 3 05101520253035 JapanNetherlandsEstoniaLatviaHungaryAust riaSwedenSloveniaGermanyLithuaniaDenmark NorwayCzech KingdomSpainCroatiaIcelandMaltaPortugalI relandItalyLuxembourgFranceCyprusBelgium RomaniaGreece 1000 2010 2013 6 antimicrobial resistance : Global report on Surveillance 2014, (WHO) 2014 17% 51% 2014 48% ( ) ( ) ( )

3 2016/6/227 2001 2014 3 2013 82016/6 (%) 3 0%40%80% % 0%40%80% 3 % 0% 40% 80% % 90%5%10%15%20%25%30%2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 1 JANIS0%5%10%15%20%25%30%2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 / ( 3 ) JANIS CTX)CTFCTXCTX 2010 1 2007 JANIS 371 722) 2 2010 3 1 2 1 1 10 (2001 2013 ) (AMR) 2013 2050 antimicrobial resistance : Tackling a crisis for health and wealth of nations, the O Neill Commission, UK, December 2014 2013 AMR 70 2050 1000 70 ( antimicrobial resistance in G7 Countriesand Beyond, G7 OECD report, Sept.

4 2015)11 G7 AMR 3 2015 G AMR 2015 6 8 2015 10 8 2015 WHO 2015 5 AMR 2016 4 16 G7 9 AMR 2016 5 26-27 12 2016 4 23-24 2 : WHO G7 WHO WHO (AMR) 13 (AMR) (2016-2020) ( ) 1.

5 2. 3. 4. 5. 6. 14 NDB ( ) ( ) AMR ( ) FETP-J, IDES )

6 (JANIS) AMR (JVARM) AMR AMR (NESID) (GenEpid-J) (JACS) 15 2016/6/22 AMR AMR AMR AMR 16 AMR

7